Omics! Omics!

A computational biologist's personal views on new technologies & publications on genomics & proteomics and their impact on drug discovery

Sunday, November 22, 2009

Targeted Sequencing Bags a Diagnosis

›
A nice complement to the one paper (Ng et al) I detailed last week is a paper that actually came out just before hand (Choi et al). Wherea...
1 comment:
Thursday, November 19, 2009

Three Blows Against the Tyranny of Expensive Experiments

›
Second generation sequencing is great, but one of it's major issues so far is that the cost of one experiment is quite steep. Just look...
1 comment:
Tuesday, November 17, 2009

Decode -- Corpse or Phoenix?

›
The news that Decode has filed for bankruptcy is a sad milestone in the history of genomics companies. Thus falls either the final or penu...
Sunday, November 15, 2009

Targeted Sequencing Bags a Rare Disease

›
Nature Genetics on Friday released the paper from Jay Shendure, Debra Nickerson and colleagues which used targeted sequencing to identify th...
Thursday, November 12, 2009

A 10,201 Genomes Project

›
With valuable information emerging from the 1000 (human) genomes project and now a proposal for a 10,000 vertebrate genome project , it...
3 comments:
Wednesday, November 11, 2009

A call for new technological minds for the genome sequencing instrument fields

›
There's a great article in the current Nature Biotechnology (alas, you'll need a subscription to read the full text) titled "T...
Tuesday, November 10, 2009

Occult Genetic Disease

›
A clinical aside by Dr. Steve over at Gene Sherpas piqued my interested recently. He mentioned a 74 year old female patient of his with lu...
2 comments:
Thursday, October 29, 2009

My Most Expensive Paper

›
Genome Research has a paper detailing the Mammalian Gene Collection (MGC) , and if you look way down on the long author list (which includes...
8 comments:
Monday, October 26, 2009

DTC CNVs?

›
Curiosity question: do the current DTC genomics companies report out copy number variations (CNVs) to their customers? Are any of their tec...
2 comments:
Saturday, October 24, 2009

Now where did I misplace that genome segment of mine?

›
One of the many interesting ASHG tidbits from the Twitter feed is a comment from "suganthibala" which I'll quote in full On a...
1 comment:

ASHG Tweets: Minor Fix or Slow Torture?

›
Okay, I'll admit it: I've been ignoring Twitter. It doesn't help that I never really learned to text (I might have sent one in ...
Thursday, October 22, 2009

Physical Maps IV: Twilight of the Clones?

›
I've been completely slacking on completing my self-imposed series on how second generation sequencing (I'm finally trying to kick t...
Wednesday, October 14, 2009

Why I'm Not Crazy About The Term "Exome Sequencing"

›
I find myself worrying sometimes that I worry too much about the words I use -- and worry some of the rest of the time that I don't worr...
6 comments:
Friday, October 09, 2009

Bad blog! Bad, bad, bad blog!

›
Thanks to Dan Koboldt from Mass Genomics, I've discovered that another blog (the Oregon Personal Injury Law Blog had copied my breast c...
2 comments:

Nano Anglerfish Snag Orphan Enzymes

›
The new Science has an extremely impressive paper tackling the problem of orphan enzymes. Due primarily to Watson-Crick basepairing, our ab...
5 comments:
Wednesday, October 07, 2009

The genomic history of a breast cancer revealed

›
Today's Nature contains a great paper which is one more step forward for cancer genomics. Using Illumina sequencing a group in British ...
7 comments:
Tuesday, October 06, 2009

Diagramming the Atari Pathway

›
Okay, it was an outside speaker at work who planted this seed in my brain, and now I can't shake the image -- but perhaps by writing thi...
1 comment:

Why does PNAS clip their RSS feeds?

›
Okay, minor pet peeve. I've pretty much switched over to using Outlook as an RSS reader to keep up with journals of interest. I still ...
2 comments:
Thursday, October 01, 2009

Pondering Polonators

›
Standing next to the Polonator like a proud relative is Kevin McCarthy, who leads the Polonator effort at Dover Systems. I had remembered h...
2 comments:
Monday, September 28, 2009

Locking in new functions

›
The September 24th Nature came in the mail today and as always with this journal (otherwise I wouldn't pay for it!) is full of interesti...
2 comments:
‹
›
Home
View web version

About Me

My photo
Keith Robison
Dr. Robison spent 10 years at Millennium Pharmaceuticals working with various genomics & proteomics technologies & working on multiple teams attempting to apply these throughout the drug discovery process. He spent 2 years at Codon Devices working on a variety of protein & metabolic engineering projects as well as monitoring a high-throughput gene synthesis facility. After a brief bit of consulting, he rejoined the cancer drug discovery field at Infinity Pharmaceuticals in May 2009. In September 2011 he joined Warp Drive Bio, a startup applying genomics to natural product drug discovery. In February 2019 he joined Ginkgo Bioworks, a synthetic biology company. Other recurring characters in this blog are his late loyal Shih Tzu Amanda, his current Shih Poo Lily and his now adult son alias TNG (The Next Generation). Dr. Robison can be reached via his Gmail account, keith.e.robison@gmail.com You can also follow him on Twitter as @OmicsOmicsBlog.
View my complete profile
Powered by Blogger.